| Field | Specification |
|---|---|
| Mfr No | |
| Concentration | |
| Form | liquid |
| Molecular Weight | |
| Product Type | |
| Relative Density | |
| Shipping | |
| Storage |
Overview
These Water-Soluble Iron Oxide Nanoparticles are superparamagnetic nanoparticles with excellent colloidal stability. They are prepared by thermodecomposition method and each nanoparticle is a single crystal with a structure either maghemite or magnetite. Using our proprietary monolayer polymer coating strategy, These successfully converted hydrophobic, organic ligand-coated IO nanoparticles into water soluble iron oxide nanoparticles. These nanoparticles are made to be very stable against harsh working conditions.
Key Features
- Narrow size distribution
- High colloidal stability
- Easy purification with magnetic column developed by Ocean NanoTech
Physical & Chemical Properties
- pH: 6.0 - 8.0 at 25 °C (77 °F)
- Chemical Stability: Stable under recommended storage conditions.
- Solvent: Water
- Appearance / Color: brown/black
These are superparamagnetic iron oxide nanoparticles (10–30 nm, 5 mg/mL) dispersed in deionized water with an amphiphilic polymer coating for aqueous colloidal stability. The unmodified surface allows conjugation with various functional groups after ligand exchange, making them a versatile starting point for custom functionalization.
Water-Soluble Iron Oxide Nanoparticles have a polymer coating that provides aqueous stability but no specific reactive functional group for direct bioconjugation. Carboxyl, Amine, PEG, and other functionalized variants have defined surface chemistry enabling specific coupling strategies. Choose unmodified nanoparticles when you plan to apply your own ligand exchange or coating protocol.
Applications include MRI contrast agent research, magnetic particle imaging (MPI), in vitro diagnostic (IVD) magnetic assay development, small molecule drug delivery studies, immunotherapy, hyperthermia research, and vaccine adjuvant studies.
The polymer coating provides stability in aqueous media; however, buffer ionic strength, pH, and protein content can affect colloidal stability. Always disperse by bath sonication before use. Test stability in your specific assay buffer before full-scale use and avoid ionic strengths above physiological range without validation.
Available in 10, 15, 20, 25, and 30 nm particle sizes. A combo pack containing three sizes is available for screening applications. See the variant selector above for current size and volume options.
The following customization and add-on services are available for this product through the supplier. For inquiries and pricing, contact support@biohippo.com.
Customization Options
- Custom Nanoparticle Synthesis: Iron oxide nanoparticles with customized particle sizes (nanometers to micrometers), narrow size distributions, surface coatings, and functional groups can be synthesized for specialized imaging, drug delivery, or sensing applications.
- Custom Surface Modification: Deep understanding of surface chemistry allows custom modification of iron oxide nanoparticle surfaces for different applications — including custom PEG lengths, targeting ligands, or specific reactive groups.
- Custom Conjugation Service: Pre-conjugated iron oxide nanoparticle–antibody, nanoparticle–protein, or nanoparticle–drug conjugates can be prepared using your supplied biomolecule. The supplier specializes in conjugation chemistry across iron oxide nanoparticles, quantum dots, magnetic beads, and latex beads.
- Assay Development: Technical support for magnetic nanoparticle-based in vitro diagnostic assay development, including magnetic sensing assays and lateral flow platforms, is available.
- Bulk & OEM Manufacturing: Bulk iron oxide nanoparticle supply and OEM manufacturing for diagnostic and therapeutic research device development are available.
To inquire about customization options, request a quote, or discuss OEM manufacturing, contact support@biohippo.com.
- Rezaei E et al. (2026). A deep dive into ferritin nanoparticle advancements: experimental and computational perspectives. Discov Nano. DOI: 10.1186/s11671-026-04577-8 PMID: 42018247
- Amaolo A et al. (2026). Breaking Through the Barrier: Nanoparticle-Driven MRI Strategies for Diagnosis and Therapy of Pancreatic Cancer. ACS Nanosci Au. DOI: 10.1021/acsnanoscienceau.5c00116 PMID: 42004273
- Fan Y et al. (2026). Bio-magnetic nanomedicine for targeted drug delivery of breast cancer: green synthesis, functional design, and translational challenges. Breast Cancer Res. DOI: 10.1186/s13058-026-02278-9 PMID: 42002783
- Morais B et al. (2026). Integrating green chemistry into SPION development: a theranostic study on prostate cell models. Nanoscale. DOI: 10.1039/d6nr00113k PMID: 41954586
- Dong J et al. (2026). Advancements in nanomaterials for the treatment and management of vascular surgeries: from drug delivery to biomedical implants. Front Bioeng Biotechnol. DOI: 10.3389/fbioe.2026.1788897 PMID: 41953561
- Galarza-Arévalo GE et al. (2026). Clinical Applications and Future Prospects of Metallic Nanoparticles in Diagnosis and Therapy. Int J Nanomedicine. DOI: 10.2147/IJN.S567931 PMID: 42023082